In anterior uveitis with secondary glaucoma, all mydriatics can be given, except
**Core Concept**
The question tests the understanding of managing anterior uveitis with secondary glaucoma, focusing on the appropriate use of mydriatics. **Mydriatics** are used to dilate the pupil, reducing pain and preventing synechiae formation. However, in the context of secondary glaucoma, the choice of mydriatic is critical.
**Why the Correct Answer is Right**
In anterior uveitis with secondary glaucoma, most mydriatics can be used, but the key is to avoid those that can further increase intraocular pressure (IOP). **Pupillary dilation** can increase IOP in certain conditions. The correct answer is related to the specific mydriatic that should be avoided due to its potential to exacerbate glaucoma.
**Why Each Wrong Option is Incorrect**
**Option A:** May not be the correct answer because some mydriatics are still safe in this context.
**Option B:** Could be a plausible choice but might not be the most critical exception.
**Option C:** Might seem like a reasonable option but understanding the specific mechanism of each mydriatic is key.
**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that in the management of anterior uveitis with secondary glaucoma, the choice of mydriatic must consider the potential impact on IOP. **Atropine**, a common mydriatic, can be used cautiously.
**Correct Answer:** D. Pilocarpine is not typically used as a mydriatic; it's a miotic, but among common mydriatics, the one to avoid in glaucoma due to potential IOP increase would be the key. **Correct Answer: D. Pilocarpine.**